Fundraising FoxShangPharma Innovation
Venture capitalSouth San Francisco · Seed–Series A · 2 people tracked
Find your way into ShangPharma Innovation
Sign up to see every warm intro you have to ShangPharma Innovation
- Paths you didn't know you had: your email and LinkedIn already hold routes to the ShangPharma Innovation team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
ShangPharma Innovation is a venture capital firm focused on pharmaceutical development and discovery. The firm invests in healthcare companies across various development stages.
Team · 2 people
from public directories
Frequently asked questions
- What stage does ShangPharma Innovation invest at?
- ShangPharma Innovation invests at the Seed, Series A stages.
- What sectors does ShangPharma Innovation focus on?
- ShangPharma Innovation focuses on Biotech, Medical Devices.
- Where is ShangPharma Innovation located?
- ShangPharma Innovation is headquartered in South San Francisco, US.
Similar investors
ACT Venture Capital is an independent Irish venture capital firm that invests €1 million to €15 million in growth-stage private companies, with capacity for larger commitments through syndicated rounds.
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests in technology companies from seed to growth stage. Since inception it has backed over 200 companies and raised more than $1.3 billion.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Blackbird is a venture capital firm that backs founders from the earliest stages, with a focus on ambitious technology startups across Australia and New Zealand.
Breyer Capital is an early-stage, high-conviction investment firm with a dedicated healthcare and life sciences practice backing founders rebuilding medicine at the intersection of science, data, care delivery, and economics.